Loading, Please Wait...
Since the founding of our company in 2004, Medicilon (stock code : 688202.SH) has grown into one of the professional drug discovery contract research organizations (CRO) in China. Over the years, we keep improving our service system in biotechnology and pharmaceutical research. Our service now spans cross medicinal chemistry, process chemistry, in vitro and in vivo DMPK, preclinical development and bioanalytical support.
